KAYLA HOLZER: Open Payments
NPI 1649901869 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,303 in 138 payments from 22 companies in 2025. Trend: 2023 $668 · 2024 $2,400 · 2025 $2,303
Food & beverage: $2,303
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $426 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $417 |
| Amgen Inc. | 18 | $242 |
| PFIZER INC. | 14 | $226 |
| Lilly USA, LLC | 10 | $164 |
| Axsome Therapeutics, Inc. | 6 | $124 |
| Novo Nordisk Inc | 6 | $99 |
| Phathom Pharmaceuticals, Inc. | 6 | $98 |
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Neurocrine BioSciences, Inc. | 4 | $56 |
Products named: CAPLYTA, VRAYLAR, NURTEC ODT, MOUNJARO, QULIPTA, EVENITY, Auvelity, VOQUEZNA.
Industry payments across ND — which companies pay providers there.
